42.5
Forte Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
41.5
FY23:
38.3
FY24:
61.3
FY25:
80.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.79
FY22:
0.49
FY23:
0.65
FY24:
0.22
FY25:
2.19
Total assets
Change from FY21 to FY25
millions USD
FY21:
43.3
FY22:
42.0
FY23:
39.0
FY24:
61.6
FY25:
82.8
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.76
FY22:
3.18
FY23:
3.67
FY24:
9.08
FY25:
20.8
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
1.04
(positive)
Change from FY21 to FY25
millions USD
FY21:
41.5
FY22:
38.8
FY23:
35.3
FY24:
52.5
FY25:
61.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
43.3
FY22:
42.0
FY23:
39.0
FY24:
61.6
FY25:
82.8
All amounts in millions USD